Sector valuations Gilead Sciences, Inc.

Equities

Market Closed - Nasdaq Other stock markets 16:00:00 2026-01-21 EST			5-day change	1st Jan Change
129.11 ^USD	+4.00%		+4.06%	+5.19%

01-21	Gilead Sciences Reports Publication of Phase 3 Trial Results of Trodelvy and Keytruda for Breast Cancer	MT
01-21	New England Journal of Medicine publishes phase 3 Ascent-04/Keynote-D19 results	RE

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	Price to Book (Y)	PEG (Y)	EV / Sales (Y)	EV / EBITDA (Y)	EV / EBIT (Y)	Dividend Yield (Y)	Capi.($)
GILEAD SCIENCES, INC.	19.26x	7.11x	0.01x	5.92x	10.84x	13.04x	2.57%	160B
ELI LILLY AND COMPANY	47.02x	36.07x	0.49x	15.57x	34.69x	37.54x	0.55%	966B
JOHNSON & JOHNSON	21.28x	6.71x	0.28x	5.87x	16.32x	17.91x	2.37%	525B
ABBVIE INC.	61.3x	903.71x	1.29x	7.19x	17.25x	17.82x	3.03%	382B
ROCHE HOLDING AG	20.66x	7.04x	0.33x	5.03x	12.45x	14.08x	2.87%	371B
ASTRAZENECA PLC	27.47x	6.19x	0.61x	5.12x	15.18x	15.99x	1.81%	278B
NOVARTIS AG	20.12x	6.44x	0.96x	5.35x	12.54x	13.62x	2.85%	276B
MERCK & CO., INC.	14.15x	5.11x	0.86x	4.64x	9.98x	11.23x	2.91%	276B
NOVO NORDISK A/S	16.19x	8.78x	8.06x	5.74x	11.86x	13.74x	3.11%	260B
AMGEN INC.	26.85x	20.45x	0.39x	6.32x	10.82x	14.51x	2.78%	185B
PFIZER INC.	12.9x	1.63x	0.3x	3.08x	7.72x	8.99x	6.6%	147B
VERTEX PHARMACEUTICALS INCORPORATED	29.72x	6.17x	-0.04x	8.94x	19.35x	20.09x	-.--%	117B
BRISTOL-MYERS SQUIBB COMPANY	13.97x	5.54x	-0.07x	3.02x	9.02x	9.55x	4.52%	111B
SANOFI	11.68x	1.22x	0.25x	2.46x	8.03x	8.86x	5.25%	111B
GSK PLC	13.22x	4.99x	0.12x	2.64x	7.63x	8.93x	3.62%	96.35B
CHUGAI PHARMACEUTICAL CO., LTD.	31.93x	6.93x	3x	10.27x	20.16x	21.54x	3.05%	86.54B
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	45.03x	6.63x	1.35x	10.9x	35.87x	37.73x	0.46%	57.39B
TAKEDA PHARMACEUTICAL COMPANY LIMITED	41.61x	1.14x	0.56x	2.61x	9.73x	27.5x	4.02%	49.69B
BAYER AG	181.84x	1.28x	-1.67x	1.61x	7.72x	13.77x	0.26%	49.05B
Average	34.54x	54.90x	0.90x	5.91x	14.59x	17.18x	2.77%	237.07B
Weighted average by Cap.	31.72x	89.16x	0.98x	7.68x	18.03x	19.98x	2.38%